Prostate Cancer - Results from #25900

Is sampling transitional zone in patients who had prior negative prostate biopsy necessary? - Abstract May 14, 2012

Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis - Abstract May 14, 2012

Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer - Abstract May 14, 2012

The needs of carers of men with prostate cancer and barriers and enablers to meeting them: A qualitative study in England - Abstract May 14, 2012

When serial prostate biopsy is recommended: Most cancers detected are clinically insignificant - Abstract May 14, 2012

Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapy interventions - Abstract May 14, 2012

Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors - Abstract May 14, 2012

The influence of antidiabetic medications on the development and progression of prostate cancer - Abstract May 14, 2012

Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases - Abstract May 14, 2012

Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: A rationale for increasing abiraterone exposure or combining with MDV3100 - Abstract May 11, 2012

Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens - Abstract May 11, 2012

Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor - Abstract May 11, 2012

Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysis - Abstract May 11, 2012

Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation - Abstract May 11, 2012

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States - Abstract May 11, 2012

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer - Abstract May 11, 2012

Development of novel immune interventions for prostate cancer - Abstract May 11, 2012

Combining immunological and androgen-directed approaches: An emerging concept in prostate cancer immunotherapy - Abstract May 11, 2012

Circumcision and the risk of prostate cancer - Abstract May 11, 2012

Central adiposity and prostate cancer in a Black population - Abstract May 10, 2012

Page 1296 of 1436